Mesna Injection 10 mL Multiple-Dose Vial by Sagent (RX)

Powerful Protection Against Chemotherapy Side Effects

Mesna Injection 10 mL Multiple-Dose Vial by Sagent is a hospital-grade, FDA-approved solution designed for those undergoing chemotherapy. Mesna (sodium 2-mercaptoethane sulfonate) is used to prevent and reduce the risk of hemorrhagic cystitis caused by toxic metabolites of chemotherapy drugs such as ifosfamide and cyclophosphamide. Easy-to-administer and fast-acting, Mesna Injection is a vital supportive care medication for cancer patients.

Medical Uses & Indications

• Cancer Chemotherapy Supporting Agent: Recommended for patients receiving ifosfamide or high-dose cyclophosphamide.
• Prevention of Bladder Toxicity: Helps avoid complications like hematuria, dysuria, and chronic inflammation.
• Suitable for Both Adult and Pediatric Oncology Patients.

Benefits of Mesna Injection 10 mL Multiple-Dose Vial

• Prevents Chemotherapy-Induced Hemorrhagic Cystitis: Effectively binds and detoxifies harmful acrolein in the urinary tract, drastically reducing the risk of severe bladder irritation and bleeding.
• Superior Patient Safety: Minimizes urinary tract toxicity, providing essential bladder protection during aggressive cancer treatment regimens.
• Manufactured by Sagent: This hospital-trusted multiple-dose vial ensures consistency, sterility, and reliability with every use.
• Ready-to-Use, Multi-Dose Vial: Designed for optimal convenience in clinical settings, allowing tailored dosing for pediatric and adult patients.
• Rapid Onset & Reliable Absorption: Ensures dependable protection throughout your chemotherapy cycle.

Purpose: Mesna (sodium-2-mercaptoethane sulfonate) works by binding to and inactivating a toxic metabolite (acrolein) produced by certain chemotherapy agents, which can otherwise damage the bladder lining.
Administration: It is administered intravenously (into a vein) by a doctor or nurse in a medical facility, typically at the same time as, and in the hours following, the chemotherapy treatment. The typical dosage is 60% of the ifosfamide dose.
Manufacturer: Sagent Pharmaceuticals, which is partnered with Strides Arcolab, has received FDA approval for and markets the generic Mesna injection in the U.S..
Dosage Form: It is available as a 100 mg/mL solution in a 10 mL multiple-dose vial for injection.
Availability: Sagent's Mesna injection is currently available, though it has experienced shortages in the pas

Why Choose Mesna Injection by Sagent?

Mesna Injection 10 mL by Sagent is trusted by leading oncologists and healthcare facilities for its uncompromising quality, flexible dosing, and efficacy in minimizing life-threatening complications during chemotherapy. If you or your patients are seeking maximum protection from chemotherapy-related urinary tract complications, this is the gold-standard product.

Order your Mesna Injection 10 mL Multiple-Dose Vial by Sagent today and ensure optimal protection during chemotherapy. Wholesale, pharmacy, and hospital supply orders available. Fast, secure shipping and full manufacturer support included.

Give cancer patients the superior safeguard they need—choose Mesna Injection 10 mL Multiple-Dose Vial by Sagent for proven, proactive protection.